SERRA, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 2.009
EU - Europa 406
AS - Asia 282
SA - Sud America 27
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.732
Nazione #
US - Stati Uniti d'America 1.998
SE - Svezia 103
IN - India 99
SG - Singapore 98
IT - Italia 92
UA - Ucraina 88
CN - Cina 83
FI - Finlandia 59
AR - Argentina 26
GB - Regno Unito 14
DE - Germania 13
IE - Irlanda 12
RO - Romania 12
CA - Canada 9
BE - Belgio 6
TG - Togo 6
BG - Bulgaria 4
CH - Svizzera 2
IR - Iran 2
MX - Messico 2
CL - Cile 1
DZ - Algeria 1
EU - Europa 1
RU - Federazione Russa 1
Totale 2.732
Città #
Fairfield 270
Chandler 198
Woodbridge 166
Ashburn 139
Dearborn 126
Ann Arbor 124
Seattle 111
Wilmington 106
Houston 94
Cambridge 88
San Paolo di Civitate 73
Princeton 61
Plano 55
Singapore 51
Boston 49
Lawrence 49
Beijing 44
Jacksonville 31
San Diego 26
Federal 25
Andover 21
Falls Church 17
Boardman 16
Des Moines 14
Millbury 13
Dublin 11
Rome 11
Norwalk 9
Santa Clara 9
Brussels 6
Helsinki 6
Lomé 6
Toronto 6
Hefei 5
Kunming 5
Mannheim 4
Nanjing 4
Sofia 4
Bühl 3
Guangzhou 3
Laurel 3
Los Angeles 3
Ottawa 3
San Mateo 3
Bern 2
Chengdu 2
Fuzhou 2
Mexico City 2
Nanchang 2
Verona 2
Zanjan 2
Algiers 1
Auburn Hills 1
Bielefeld 1
Bologna 1
Bremen 1
Changsha 1
Chions 1
Dallas 1
Fort Worth 1
Fremont 1
Grafing 1
Guiyang 1
Hangzhou 1
Harbin 1
Hebei 1
Hounslow 1
Indiana 1
Jiaxing 1
Jinan 1
Las Vegas 1
Leawood 1
Letterkenny 1
Mcallen 1
Nottingham 1
Plattsmouth 1
Pomezia 1
Provo 1
Quzhou 1
Redmond 1
Southend 1
Tappahannock 1
Washington 1
Xian 1
Zhengzhou 1
Totale 2.119
Nome #
Aorto-femoral graft infections: a clinical and microbiological analysis. 102
Exogenous lipids clearance in cirrhotic patients 89
Circulating CD34+ cells are decreased in chronic obstructive pulmonary disease 87
ATRIAL NATRIURETIC PEPTIDE, RENIN AND ALDOSTERONE IN OBSTRUCTIVE LUNG-DISEASE AND HEART-FAILURE 78
Exogenous lipid clearance in compensated liver cirrhosis 73
Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients 73
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. 73
Brain Dysfunction in Respiratory Failure 71
Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. 70
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 70
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 69
EFFECTS OF FENOTEROL ON OXYGEN-TRANSPORT IN PATIENTS WITH CHRONIC AIR-FLOW OBSTRUCTION 66
Health care associated pneumonia: a new clinical entity. 66
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study 65
Role of multidrug-resistant pathogens in health-care-associated pneumonia 65
Arthritis as a rare side effect of phenytoin therapy. 64
Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia 63
Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients 62
Aortofemoral graft infection: the usefulness of 99mTC-HMPAO-labelled leukocyte scan. 61
Effect of reduced body weight on muscle aerobic capacity in patients with COPD 60
OXYGEN EFFECT ON O-2 DEFICIT AND VO2 KINETICS DURING EXERCISE IN OBSTRUCTIVE PULMONARY-DISEASE 59
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 59
Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus 57
EFFECT OF INORGANIC-PHOSPHATE IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE PATIENTS DURING EXERCISE 54
A case of brain abscess due to Brucella melitensis. 53
Successful treatment of disseminated cerebritis complicating methicillin-resistant staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid 53
The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity 53
CARDIOPULMONARY EXERCISE TESTING IN THE EVALUATION OF PATIENTS WITH VENTILATORY VS CIRCULATORY CAUSES OF REDUCED EXERCISE TOLERANCE 52
Non-tubercular and non-brucellar spondylodiscitis: preliminary clinico-microbiologic analysis of 37 cases 50
CD4+ T-lymphocitopenia and Pneumocistis carinii pneumonia in a patient with miliary tuberculosis 47
REGULATION OF ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN NORMAL HUMANS 46
EFFECT OF OXYGEN ON NA+ EXCRETION IN HYPOXEMIC CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) PATIENTS 44
Incidence of acid-base and electrolyte disturbances in a general hospital: a study of 110 consecutive admissions. 44
Alveolar cell population in HIV infected patients 43
ATRIAL NATRIURETIC PEPTIDE (ANP) RESPONSE TO INTRATHORACIC PRESSURE (ITP)ELEVATION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) AND IN CHRONIC HEART-DISEASE (CHD) PATIENTS 42
[Study of bronchoalveolar lavage in febrile patients with AIDS or AIDS-related syndrome]. 42
[Relapsing polychondritis: a case with anticartilage, anticardiolipin and anticentromere antibodies]. 42
NUTRITIONAL STATE AND EXERCISE TOLERANCE IN PATIENTS WITH COPD 41
Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients 39
[A combination of fenoterol and ipratropium bromide administered by inhalation. Evaluation of its effectiveness and tolerance in a long-term study]. 38
COMPARISON OF CARDIORESPIRATORY RESPONSES TO O-2 AT REST AND EXERCISE - HYPERCAPNIC VS NORMOCAPNIC OBSTRUCTIVE LUNG-DISEASE PATIENTS 37
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON SODIUM AND WATER-EXCRETION 36
EFFECT OF OXYGEN ON O2 KINETICS AND OTHER CARDIORESPIRATORY PARAMETERS DURING EXERCISE IN COPD 34
TOLERANCE TO INHALED DUOVENT - A LONG-TERM STUDY 32
PHARMACOLOGICAL ELEVATION OF PLASMA INORGANIC-PHOSPHATE IN HYPOXEMIC OBSTRUCTIVE LUNG-DISEASE 32
Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii. 32
PLASMA ATRIAL NATRIURETIC PEPTIDE (ANP), RENIN-ACTIVITY (PRA), AND ALDOSTERONE (PA) IN CHRONIC OBSTRUCTIVE LUNG-DISEASE (COLD) 31
MODULATION OF ATRIAL NATRIURETIC PEPTIDE RELEASE IN NORMALS 30
Plasminogen activator production in a rat model of Pneumocystis carinii pneumonae 29
The effect of body weight and arterial hypoxemia on peak oxygen uptake (VO2 peak) and VO2 kinetics (tau VO2) in COPD. 26
EFFECT OF POSITIVE AND NEGATIVE-PRESSURE BREATHING ON RENAL SODIUM AND WATER-EXCRETION 25
Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus 24
Pharmacologic elevation of blood inorganic phosphate (Pi) in hypoxemic patients with COPD. 20
Totale 2.773
Categoria #
all - tutte 7.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020623 0 0 5 46 80 140 106 80 66 49 36 15
2020/2021151 21 22 7 15 4 6 2 20 19 19 13 3
2021/2022566 1 31 56 32 63 12 13 55 56 42 77 128
2022/2023630 113 181 41 77 62 59 6 25 46 4 11 5
2023/2024157 22 31 4 11 11 6 1 6 0 30 17 18
2024/202568 25 19 24 0 0 0 0 0 0 0 0 0
Totale 2.773